Corrigendum: Interpretation guidance for MHRA regulatory considerations for phage therapeutic products

20260 citationsJournal Articlediamond Open Access

Authors

Carmen Coxon · National Institute for Biological Standards and Control

Elizabeth Bell · National Institute for Health and Care Excellence

Evelien Adriaenssens · Innovate UK

Jason Clark · Innovate UK

JJ Edwards · Innovate UK

Tas Gohir · Guy's and St Thomas' NHS Foundation Trust

Francesca E. Hodges

Abstract

Microbiology Society journals contain high-quality research papers and topical review articles. We are a not-for-profit publisher and we support and invest in the microbiology community, to the benefit of everyone. This supports our principal goal to develop, expand and strengthen the networks available to our members so that they can generate new knowledge about microbes and ensure that it is shared with other communities.

Topics & Keywords

Bacteriophages and microbial interactions Monoclonal and Polyclonal Antibodies Research vaccines and immunoinformatics approaches

Publication Details

Published in: Microbiology

Volume 172, Issue 2

DOI: 10.1099/mic.0.001670

Field-Weighted Citation Impact: 0.00

Command Palette

Corrigendum: Interpretation guidance for MHRA regulatory considerations for phage therapeutic products

Authors

Abstract

Topics & Keywords

Publication Details